|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 265, Issue 2 E314-E322, Copyright © 1993 by American Physiological Society
ARTICLES |
O. P. McGuinness, T. Fugiwara, S. Murrell, D. Bracy, D. Neal, D. O'Connor and A. D. Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232.
The effects of chronic administration of counterregulatory hormones on hepatic glycogenolysis and gluconeogenesis were investigated. We studied 14 20-h fasted conscious dogs prior to (day 0) and after a 70-h stress hormone (SHI, n = 7) or saline (n = 7) infusion (day 3). Glucose production and gluconeogenesis were assessed using tracer and arteriovenous difference techniques. SHI increased plasma glucagon, cortisol, epinephrine, and norepinephrine levels approximately fivefold. SHI increased the arterial plasma glucose and insulin concentrations (110 +/- 2 to 204 +/- 19 mg/dl and 13 +/- 2 to 36 +/- 3 microU/ml on day 3). Tracer-determined glucose appearance and net hepatic glucose output were increased 80 and 60%, respectively. Net hepatic lactate uptake and fractional extraction were increased by 11.2 +/- 3.8 and 0.51 +/- 0.18 mumol.kg-1 x min-1, respectively, as was net hepatic glycerol uptake (1.0 +/- 0.6 mumol.kg-1 x min-1). Net hepatic fractional alanine extraction was also increased by 0.37 +/- 0.03 mumol.kg-1 x min-1; however, net hepatic alanine uptake was not altered. The efficiency of alanine conversion to glucose almost doubled (0.33 +/- 0.05 to 0.59 +/- 0.09). Renal glucose production was also increased, accounting for 33% of the increase in glucose turnover. This increase was paralleled by an increase in renal gluconeogenic precursor uptake. In conclusion, SHI created marked hyperglycemia and hyperinsulinemia and elevated glucose production from both the liver and the kidney, with gluconeogenesis accounting for approximately 70% of the response.
This article has been cited by other articles:
![]() |
F.-Y. Chueh, C. Malabanan, and O. P. McGuinness Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1206 - E1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grubert, M. Lautz, D. B. Lacy, M. C. Moore, B. Farmer, A. Penaloza, A. D. Cherrington, and O. P. McGuinness Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E232 - E240. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basi, L. B. Pupim, E. M. Simmons, M. T. Sezer, Y. Shyr, S. Freedman, G. M. Chertow, R. L. Mehta, E. Paganini, J. Himmelfarb, et al. Insulin resistance in critically ill patients with acute renal failure Am J Physiol Renal Physiol, August 1, 2005; 289(2): F259 - F264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, C. A. DiCostanzo, D. Dardevet, M. Lautz, B. Farmer, and A. D. Cherrington Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E556 - E563. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Chen, C. J. Torres-Sanchez, N. Hosein, Y. Zhang, D. B. Lacy, and O. P. McGuinness Time course of the hepatic adaptation to TPN: interaction with glycogen depletion Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E163 - E170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, P. Galassetti, K. Igawa, D. K. Sindelar, D. W. Neal, M. Burish, and A. D. Cherrington Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E291 - E301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Goldstein, L. Rossetti, B. A. J. Palmer, R. Liu, D. Massillon, M. Scott, D. Neal, P. Williams, B. Peeler, and A. D. Cherrington Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E946 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Edgerton, S. Cardin, M. Emshwiller, D. Neal, V. Chandramouli, W. C. Schumann, B. R. Landau, L. Rossetti, and A. D. Cherrington Small Increases in Insulin Inhibit Hepatic Glucose Production Solely Caused by an Effect on Glycogen Metabolism Diabetes, August 1, 2001; 50(8): 1872 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Gerich, C. Meyer, H. J. Woerle, and M. Stumvoll Renal Gluconeogenesis: Its importance in human glucose homeostasis Diabetes Care, February 1, 2001; 24(2): 382 - 391. [Abstract] [Full Text] |
||||
![]() |
C. M. Donmoyer, S.-S. Chen, S. A. Hande, D. B. Lacy, J. Ejiofor, and O. P. McGuinness Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E235 - E243. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, D. K. Sindelar, K. Igawa, S. Sherck, D. W. Neal, M. Emshwiller, and A. D. Cherrington The direct effects of catecholamines on hepatic glucose production occur via alpha 1- and beta 2-receptors in the dog Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E463 - E473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lekas, S. J. Fisher, B. El-Bahrani, M. van Delangeryt, M. Vranic, and Z. Q. Shi Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade J Appl Physiol, August 1, 1999; 87(2): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sindelar, K. Igawa, C. A. Chu, J. H. Balcom, D. W. Neal, and A. D. Cherrington Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E806 - E813. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stumvoll, C. Meyer, G. Perriello, M. Kreider, S. Welle, and J. Gerich Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E817 - E826. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, D. K. Sindelar, D. W. Neal, E. J. Allen, E. P. Donahue, and A. D. Cherrington Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E162 - E171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shiota, P. A. Jackson, H. Bischoff, M. McCaleb, M. Scott, M. Monohan, D. W. Neal, and A. D. Cherrington Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E868 - E879. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sindelar, C. A. Chu, D. W. Neal, and A. D. Cherrington Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E972 - E980. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. McGuinness, V. Shau, E. M. Benson, M. Lewis, R. T. Snowden, J. E. Greene, D. W. Neal, and A. D. Cherrington Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E674 - E681. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, S. M. Sherck, K. Igawa, D. K. Sindelar, D. W. Neal, M. Emshwiller, and A. D. Cherrington Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E402 - E411. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |